Realistic expectations of prepulse inhibition in translational models for schizophrenia research.
about
Pharmacology of hallucinations: several mechanisms for one single symptom?Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour?The effects of the dopamine D2 agonist sumanirole on prepulse inhibition in rats.Evaluation of the clinical efficacy of asenapine in schizophreniaEvaluating the antipsychotic profile of the preferential PDE10A inhibitor, papaverineKalirin regulates cortical spine morphogenesis and disease-related behavioral phenotypesPhospholipase C-β1 Hypofunction in the Pathogenesis of Schizophrenia.Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits.Adenosine kinase: exploitation for therapeutic gain.Towards medication-enhancement of cognitive interventions in schizophreniaA conceptual and practical guide to the behavioural evaluation of animal models of the symptomatology and therapy of schizophrenia.Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophreniaAnesthesia with sevoflurane in neonatal rats: Developmental neuroendocrine abnormalities and alleviating effects of the corticosteroid and Cl(-) importer antagonists.Inhibition of parvalbumin-expressing interneurons results in complex behavioral changes.Gsx1 expression defines neurons required for prepulse inhibition.Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia PharmacotherapyInvestigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies.Stereochemical and neuroanatomical selectivity of pramipexole effects on sensorimotor gating in ratsInhibition of phosphodiesterase 10A has differential effects on dopamine D1 and D2 receptor modulation of sensorimotor gating.Long-term effects of environmentally relevant doses of 2,2',4,4',5,5' hexachlorobiphenyl (PCB153) on neurobehavioural development, health and spontaneous behaviour in maternally exposed mice.Increased behavioral and neuronal responses to a hallucinogenic drug in PACAP heterozygous mutant mice.Animal models of neuropsychiatric disordersGating Deficit Heritability and Correlation With Increased Clinical Severity in Schizophrenia Patients With Positive Family HistoryBACE1 across species: a comparison of the in vivo consequences of BACE1 deletion in mice and ratsDifferential Neural Responses Underlying the Inhibition of the Startle Response by Pre-Pulses or Gaps in Mice.Using a maternal immune stimulation model of schizophrenia to study behavioral and neurobiological alterations over the developmental course.Fronto-temporal-mesolimbic gene expression and heritable differences in amphetamine-disrupted sensorimotor gating in rats.Memantine Effects On Sensorimotor Gating and Mismatch Negativity in Patients with Chronic Psychosis.Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study.Negative visuospatial priming in isolation-reared rats: Evidence of resistance to the disruptive effects of amphetamine.Cortical network dysfunction caused by a subtle defect of myelination.Clozapine N-Oxide Administration Produces Behavioral Effects in Long-Evans Rats: Implications for Designing DREADD Experiments.Reduced Prepulse Inhibition as a Biomarker of Schizophrenia.Habituation of the startle reflex depends on attention in cannabis users.Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia.Adolescent olanzapine sensitization is correlated with hippocampal stem cell proliferation in a maternal immune activation rat model of schizophreniaInhibition in the Human Auditory Cortex.Adult response to olanzapine or clozapine treatment is altered by adolescent antipsychotic exposure: a preclinical test in the phencyclidine hyperlocomotion modelDiscordant behavioral effects of psychotomimetic drugs in mice with altered NMDA receptor functionFunctional Dissociation of Group III Metabotropic Glutamate Receptors Revealed by Direct Comparison between the Behavioral Profiles of Knockout Mouse Lines.
P2860
Q21284720-B64551B6-BF78-46DF-A79D-BB59FE0254AAQ22306157-9558463D-F394-48AC-BFAC-0EA2B08FE2C9Q24628933-784A306D-639D-4ACD-B51C-506452912FE5Q24630385-1178014A-CD71-42A6-B445-4333E37A2D2BQ24649503-F71B5DDB-0EBC-4644-8557-F04D6D9F17D7Q24655969-01F7A671-E94B-436A-B8AF-A0B04A284199Q26774767-AC2AF609-B5CA-4B95-8295-FC7AB9D76067Q26830533-A8280622-FB25-4DE6-B29E-13F983F68B82Q26852056-4BE616A8-CDE6-4862-A0F8-3BE410A3E2FCQ26860777-902D1F3E-AAFC-43F5-A6A4-5350F5D10397Q27001119-FD10E310-8F52-4056-9D26-04688768C512Q27014120-11203C1E-20C9-4F50-9D9F-A37066B455C3Q27304384-331235CA-3371-494E-8720-DE39B6868791Q27319891-3D4272FF-1FD1-43C0-A7D7-3945F6632B52Q27320104-B0A0BA30-E532-4EA1-AB71-350E289F3BDEQ28078534-8274D84F-F258-4505-8AAB-977BE64C8ECDQ28085253-585A1166-DD08-4333-B930-FC35F189E4C8Q28256971-60329B8F-7F36-4CDB-B3C9-0A3FF64C2FA9Q28385659-9DE51DAF-BD06-42E4-ABFB-55418CCD4066Q28386091-2AF58C07-20D2-41EA-B7B7-6A6C3DDFCA66Q28539999-F96CA689-9CE1-4D05-ABBE-84B5954D8061Q29619899-E03EF539-C2E6-466A-82BC-8EA02520B61BQ30359621-71C95767-B590-4892-A9DC-97F29E10F63BQ30361192-AA19B0A4-5F4A-4071-8856-6AD3B90D1EE3Q30362692-589EC5D9-7025-4C08-8F10-EAFF93F319D2Q30365823-65E26BA4-BAB9-4021-B693-91ABA6D5594EQ30366139-9A0C938B-C6AC-44EF-A6ED-C7EB90D6D9C7Q30366961-DE61EB6F-0176-4272-8373-E6937F056456Q30367047-F67D7631-CD75-4E87-95AE-9E5E27F2436AQ30368568-9B489BED-590C-424B-81B0-EFEEA871E424Q30368997-76C0C6A4-DEA3-4DC7-A15A-27D09D98232EQ30370324-EBB9CF80-4B43-404E-8768-A8C70E055D91Q30370952-B94DB3DC-4FCE-4B48-956C-5A09104B673CQ30371361-AC0D7031-54BC-4507-BEDF-97A93F27780CQ30375583-BD9C68AC-D4F7-452A-887B-57F92454B82EQ30375799-9A31ECB2-395C-44CA-94F3-0CAE4E59B5C1Q30381848-D9E08D6A-4268-431D-83BF-413E7F5735B3Q30386851-8FD42848-3B7C-4D2D-972B-7FB817C92EF8Q30386868-D45158C0-C0C9-4CC4-9D83-56F872843353Q30390870-B038E331-64D5-4024-B68A-037FB25CC362
P2860
Realistic expectations of prepulse inhibition in translational models for schizophrenia research.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Realistic expectations of prep ...... els for schizophrenia research
@nl
Realistic expectations of prep ...... ls for schizophrenia research.
@ast
Realistic expectations of prep ...... ls for schizophrenia research.
@en
type
label
Realistic expectations of prep ...... els for schizophrenia research
@nl
Realistic expectations of prep ...... ls for schizophrenia research.
@ast
Realistic expectations of prep ...... ls for schizophrenia research.
@en
prefLabel
Realistic expectations of prep ...... els for schizophrenia research
@nl
Realistic expectations of prep ...... ls for schizophrenia research.
@ast
Realistic expectations of prep ...... ls for schizophrenia research.
@en
P2093
P2860
P3181
P1433
P1476
Realistic expectations of prep ...... ls for schizophrenia research.
@en
P2093
David L Braff
Gregory A Light
Martin Weber
Neal R Swerdlow
P2860
P2888
P304
P3181
P356
10.1007/S00213-008-1072-4
P407
P577
2008-06-21T00:00:00Z
P5875
P6179
1045736704